TROPONIN T IS A STRONG MARKER FOR CARDIOVASCULAR DISEASE IN DIALYSIS PATIENTS, DESPITE HIGH BACKGROUND LEVELS OF SERUM TROPONIN T  by Buiten, Maurits et al.
Stable Ischemic Heart Disease
A1545
JACC April 1, 2014
Volume 63, Issue 12
troPonin t is a strong marker for cardiovascUlar disease in dialysis Patients, desPite 
high BackgroUnd levels of serUm troPonin t
Poster Contributions
Hall C
Saturday, March 29, 2014, 10:00 a.m.-10:45 a.m.
Session Title: The Roles of Diabetes, Obesity, and Kidney Disease in Stable Atherosclerotic Heart Disease
Abstract Category: 25. Stable Ischemic Heart Disease: Clinical
Presentation Number: 1121-332
Authors: Maurits Buiten, Joris Rotmans, Arnoud van der Laarse, Johan Jukema, LUMC, Leiden, The Netherlands
introduction: In the general population, increased serum levels of cardiac troponin T (cTnT) are associated with cardiovascular disease. In patients 
with end-stage renal disease (ESRD) however, increased levels of cTnT are common. This could be due to the fact that cTnT is cleared by the kidneys 
or due to the heavy burden of coronary artery disease (CAD) and heart failure. The aim of this study was to investigate the value of cTnT as a marker 
of cardiac disease in ESRD patients.
methods:Serum cTnT levels were measured in a cohort of dialysis patients and related to left ventricular ejection fraction (LVEF) and left 
ventricular mass index (LVMI) using echocardiography, and to CAD (defined as ≥1 occluded coronary artery) using coronary CT-scan.
results: We included 145 dialysis patients, 67±8 y, 77% male, eGFR 6.0±2.6mL/min/1.73m2, median cTnT level 0.04(0.02-0.07µg/L). There 
was no residual kidney function in 36 patients (25%). In 122 patients (84%) cTnT level was ≥0.014µg/L. These patients had a higher LVMI (132 
vs. 108 g/m2, p=0.02) and lower LVEF (52 vs. 56%, p=0.01) compared to patients with cTnT<0.014 µg/L. In a multivariate regression model, 
the association between cTnT and all markers of cardiovascular disease was significant, and this remained so after adjusting for residual kidney 
function. (fig)
conclusions: In patients with ESRD, serum troponin T levels are associated with the presence of cardiovascular disease, despite high background 
levels of circulating troponin T.
Association between cTnT and cardiovascular disease
LVEF Beta CI p value
1. Crude association -1,96 - 3.62 - 0.30 0.02
2. Adjusted for residual kidney function -1,77 - 3.40 - 0.14 0.03
LVMI
1. Crude association 0.08 0.01 - 0.15 0.02
2. Adjusted for residual kidney function 0.08 0.01 - 0.15 0.03
CAD OR CI p-value
1. Crude association 1.82 1.05 - 3.14 0.03
2. Adjusted for residual kidney function 1.68 1.03 - 2.05 0.04
cTnT; cardiac troponin T, LVEF; left ventricular ejection fraction, LVMI; Left Ventricular Mass Index, CAD; Coronary Artery Disease (≥1 occluded 
coronary artery)
